// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Patellofemoral Bone Morphology is Related to Gender But Not Pain: 3D Quantitative Data Analysis From The OAI

M.A. Bowes - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

An Investigation of High Density Mineralised Protrusions in Human Cadaveric Knees by MRI and Microtomography

N.P. Thomas - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Potency Assay for Assessing the Chondrogenic Efficiency of Bioactive Molecules in Human Cartilage in vivo

A.-S. Thorup - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Role of Micrornas in Osteoarthritis and Ageing-Related Functional Decline in Joint Tissue Homeostasis

R. McCormick - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

TSG-6 is in Part Responsible for FGF2-dependent Chondroprotection in Murine Osteoarthritis

S. Lympany - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

TSG-6

Racial Differences in Magnetic Resonance Image-based Three-dimensional Bone Shape of the Femur Versus the Tibia at the Knee: Data from the Osteoarthritis Initiative

J.-S. Li - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

The Role of CXCl6 in Cartilage Development and Homeostasis

S. Caxaria - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changes in Expression of Heparan Sulphate-associated Genes and Composition in Human Osteoarthritic Cartilage

A. Chanalaris - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Evaluating Patients' Expectations from a Novel Patient-centered Perspective Predicts Surgical Outcome and Dissatisfaction Following Knee Arthroplasty

S.R. Filbay - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sitting Time Predicts Clinical Outcomes of Function and Physical Health in Adults with OA

J.G. Quicke - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Osteoarthritis

N/A

Change in Pain and its Relation to Activity Measures

M.J. Parkes - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An Evaluation of a New Strengthening and Exercise Programme that Aims to Improve the Symptoms of Knee Osteoarthritis by Goal Setting, using Strength to Bodyweight Ratios

J. Creasey - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Characterising movement patterns in elite male professional golfers using an observational hip and lower limb movement screen

N. Booysen - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What exactly is a good outcome for TKR? And what proportion of patients experience one?

A. Gao - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Decision algorithms for the re-treatment with viscosupplementation in patients suffering from knee osteoarthritis

Y. Henrotin - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Bone marrow lesions are associated with pain, but not with inflammatory biomarkers in end-stage knee osteoarthritis patients

M.R. Radojcic - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Knee osteoarthritis

N/A

Preoperative pain sensitization and total knee replacement outcome

Y.Y. Leung - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Changes in ion channel expression in synovial fibroblasts in an in vitro model of osteoarthritis

K. Kumagai - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Osteoarthritis

N/A

Neuromuscular comparison of the upper-leg during isometric bed exercises and functional sit-to-stand exercises in older adults

J.P. Gavin - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Epoch

Lateral wedge insoles increase activity profiles in individuals with medial knee osteoarthritis

Y.M. Althebaity - Osteoarthritis Research Society International (OARSI) , 2017

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

N/A

Copyright © 2026. QuantiNova All rights reserved